Published in Nat Rev Immunol on October 01, 2006
The development of allergic inflammation. Nature (2008) 4.52
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol (2008) 3.45
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol (2011) 2.04
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med (2008) 1.91
Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol (2008) 1.73
Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med (2013) 1.64
Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol (2015) 1.57
Mimotope vaccination for therapy of allergic asthma: anti-inflammatory effects in a mouse model. Clin Exp Allergy (2009) 1.50
Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function. Clin Exp Allergy (2010) 1.46
Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin Exp Allergy (2014) 1.45
Current status of veterinary vaccines. Clin Microbiol Rev (2007) 1.44
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation. J Clin Invest (2008) 1.43
Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination. Allergy (2016) 1.40
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Regulatory T cells in many flavors control asthma. Mucosal Immunol (2010) 1.28
Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. Mucosal Immunol (2012) 1.18
Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol (2013) 1.14
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J Immunol (2007) 1.09
T-cell subset regulation in atopy. Curr Allergy Asthma Rep (2011) 1.09
Insect sting anaphylaxis. Immunol Allergy Clin North Am (2007) 1.08
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med (2012) 1.08
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol (2014) 1.05
Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J (2015) 1.03
Immunomodulation of allergic disease. Annu Rev Med (2009) 1.02
Molecular approach to allergy diagnosis and therapy. Yonsei Med J (2014) 1.01
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine (2011) 1.01
Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol (2013) 1.00
Helminths in the hygiene hypothesis: sooner or later? Clin Exp Immunol (2014) 0.99
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Allergy as an epithelial barrier disease. Clin Transl Allergy (2011) 0.96
The human IgE repertoire. Int Arch Allergy Immunol (2013) 0.94
In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity. PLoS One (2011) 0.92
Vaccines for allergy. Curr Opin Immunol (2012) 0.90
Food allergies: the basics. Gastroenterology (2015) 0.90
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol (2016) 0.89
Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells. J Immunol (2008) 0.89
Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses. Chest (2012) 0.88
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine (2016) 0.88
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy (2012) 0.87
Nanoparticulate adjuvants and delivery systems for allergen immunotherapy. J Biomed Biotechnol (2012) 0.87
Targeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro. J Allergy Clin Immunol (2010) 0.87
Recognition of self-heat shock protein 60 by T cells from patients with atopic dermatitis. Cell Stress Chaperones (2012) 0.87
Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy. J Allergy Clin Immunol (2012) 0.87
The influence of recombinant production on the immunologic behavior of birch pollen isoallergens. PLoS One (2009) 0.86
Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy. Immunobiology (2012) 0.86
Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients. Allergy (2014) 0.86
Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun (2008) 0.86
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice. Thorax (2014) 0.86
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy. Curr Treat Options Allergy (2014) 0.86
Proteolytically inactive per a 10 allergen of Periplaneta americana modulates Th2 response and enhances IL-10 in mouse model. J Clin Immunol (2010) 0.85
Kimura's disease or IgG4-related disease? A case-based review. Clin Rheumatol (2013) 0.85
Allergen Immunotherapy: Past, Present, and Future. Allergy Asthma Immunol Res (2016) 0.84
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection. EBioMedicine (2016) 0.84
IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma. J Immunol (2010) 0.84
Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer. Mol Immunol (2010) 0.83
Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol (2012) 0.83
A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy. Immun Inflamm Dis (2014) 0.83
Induction of tolerance via the sublingual route: mechanisms and applications. Clin Dev Immunol (2011) 0.83
Pollen grains for oral vaccination. J Control Release (2014) 0.83
Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets. Proc Natl Acad Sci U S A (2016) 0.82
Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens. Clin Exp Allergy (2015) 0.82
Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice. Sci Rep (2015) 0.81
Expression of hypoallergenic Der f 2 derivatives with altered intramolecular disulphide bonds induces the formation of novel ER-derived protein bodies in transgenic rice seeds. J Exp Bot (2012) 0.81
Update on the immunological pathway of negative regulation in acute insults and sepsis. J Interferon Cytokine Res (2012) 0.81
IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach. J Carcinog Mutagen (2014) 0.81
HSP: Bystander Antigen in Atopic Diseases? Front Immunol (2012) 0.81
Identification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinum. PLoS One (2012) 0.81
Can we vaccinate against Type 1 diabetes? F1000 Biol Rep (2012) 0.81
Expression of IL-37 contributes to the immunosuppressive property of human CD4(+)CD25(+) regulatory T cells. Sci Rep (2015) 0.80
Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen. Clin Exp Allergy (2012) 0.80
Therapeutic Effects of Bee Venom on Immunological and Neurological Diseases. Toxins (Basel) (2015) 0.80
Toward precision medicine and health: Opportunities and challenges in allergic diseases. J Allergy Clin Immunol (2016) 0.79
Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction. Clin Exp Allergy (2014) 0.79
Sublingual Immunotherapy Induces Regulatory Function of IL-10-Expressing CD4(+)CD25(+)Foxp3(+) T Cells of Cervical Lymph Nodes in Murine Allergic Rhinitis Model. J Allergy (Cairo) (2012) 0.79
Allergen-specific IgG antibodies purified from mite-allergic patients sera block the IgE recognition of Dermatophagoides pteronyssinus antigens: an in vitro study. Clin Dev Immunol (2013) 0.79
Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity. Clin Exp Allergy (2016) 0.79
A naturally occurring hypoallergenic variant of vespid Antigen 5 from Polybia scutellaris venom as a candidate for allergen-specific immunotherapy. PLoS One (2012) 0.78
Schistosoma mansoni infection in preschool-aged children: development of immunoglobulin E and immunoglobulin G4 responses to parasite allergen-like proteins. J Infect Dis (2012) 0.78
Oral immunotherapy for the treatment of food allergy. Hum Vaccin Immunother (2014) 0.78
In search of a tolerance-induction strategy for cow's milk allergies: significant reduction of beta-lactoglobulin allergenicity via transglutaminase/cysteine polymerization. Clinics (Sao Paulo) (2012) 0.78
Purification, Cloning and Immuno-Biochemical Characterization of a Fungal Aspartic Protease Allergen Rhi o 1 from the Airborne Mold Rhizopus oryzae. PLoS One (2015) 0.78
A nebulized complex traditional Chinese medicine inhibits Histamine and IL-4 production by ovalbumin in guinea pigs and can stabilize mast cells in vitro. BMC Complement Altern Med (2013) 0.78
Designing a multimer allergen for diagnosis and immunotherapy of dog allergic patients. PLoS One (2014) 0.78
Therapeutic effects and biomarkers in sublingual immunotherapy: a review. J Allergy (Cairo) (2012) 0.77
Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2. Int J Nanomedicine (2011) 0.77
Mechanisms of immune tolerance to allergens in children. Korean J Pediatr (2013) 0.77
Generation of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy. Int J Clin Exp Pathol (2014) 0.77
Purification and immunobiochemical characterization of a 31 kDa cross-reactive allergen from Phaseolus vulgaris (kidney bean). PLoS One (2013) 0.77
Potential therapy of Fc-antigen combination-encoding DNA vaccination in mouse allergic airway inflammation. Clin Exp Immunol (2008) 0.77
Allergen immunotherapy in pregnancy. Allergy Asthma Clin Immunol (2015) 0.77
Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapy. J Allergy Clin Immunol (2015) 0.77
Current immunological approaches for management of allergic rhinitis and bronchial asthma. Inflamm Res (2009) 0.77
Characterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapy. Immunobiology (2013) 0.77
Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production. J Allergy Clin Immunol (2016) 0.76
Immunomodulatory Effects of Adjuvants CPG, MPLA, and BCG on the Derp2-Induced Acute Asthma at Early Life in an Animal Model of BALB/c Mice. Inflammation (2016) 0.76
AcCystatin, an immunoregulatory molecule from Angiostrongylus cantonensis, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma. Parasitol Res (2014) 0.76
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology? Clin Exp Allergy (2011) 0.76
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol (2007) 2.49
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol (2011) 2.06
Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol (2012) 2.05
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2007) 2.05
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol (2013) 1.96
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol (2004) 1.92
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med (2008) 1.91
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol (2012) 1.88
Role of Treg in immune regulation of allergic diseases. Eur J Immunol (2010) 1.82
Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol (2010) 1.80
TH17 cells in the big picture of immunology. J Allergy Clin Immunol (2007) 1.78
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J (2002) 1.66
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol (2008) 1.64
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol (2011) 1.63
Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med (2009) 1.57
High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy. J Allergy Clin Immunol (2012) 1.52
Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy. J Allergy Clin Immunol (2011) 1.49
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol (2002) 1.47
Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol (2006) 1.45
Wheat allergy in children evaluated with challenge and IgE antibodies to wheat components. Pediatr Allergy Immunol (2015) 1.44
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol (2013) 1.43
Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE. Immunol Cell Biol (2012) 1.41
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. J Immunol (2009) 1.37
A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2013) 1.36
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol (2010) 1.34
Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol (2006) 1.34
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. J Allergy Clin Immunol (2012) 1.28
T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J (2003) 1.24
Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol (2009) 1.24
Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol (2011) 1.20
Regulatory NK cells suppress antigen-specific T cell responses. J Immunol (2008) 1.18
Immune regulation by histamine. Curr Opin Immunol (2002) 1.16
MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol (2013) 1.16
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol (2011) 1.15
Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol (2002) 1.15
Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol (2013) 1.14
Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol (2005) 1.14
Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol (2004) 1.13
TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol (2011) 1.12
T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol (2002) 1.11
TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol (2012) 1.11
Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J Immunol (2009) 1.10
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J Immunol (2007) 1.09
T-cell subset regulation in atopy. Curr Allergy Asthma Rep (2011) 1.09
Impaired allergy diagnostics among parasite-infected patients caused by IgE antibodies to the carbohydrate epitope galactose-α 1,3-galactose. J Allergy Clin Immunol (2011) 1.09
Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol (2006) 1.09
IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol (2011) 1.08
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol (2007) 1.08
Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res (2010) 1.07
Recombinant allergen-based IgE testing to distinguish bee and wasp allergy. J Allergy Clin Immunol (2010) 1.07
Suggestions for the assessment of the allergenic potential of genetically modified organisms. Int Arch Allergy Immunol (2005) 1.06
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J Mol Biol (2007) 1.06
Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J Immunol (2005) 1.05
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood (2008) 1.05
B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J Allergy Clin Immunol (2007) 1.05
Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. J Immunol (2009) 1.04
Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem (2003) 1.04
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol (2005) 1.04
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur J Immunol (2002) 1.03
Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy. J Immunol (2002) 1.03
Release of allergens as respirable aerosols: A link between grass pollen and asthma. J Allergy Clin Immunol (2002) 1.03
Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest (2014) 1.03
Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol (2005) 1.03
Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol (2008) 1.03
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine (2011) 1.01
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol (2011) 1.01
Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep (2013) 1.01
Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol (2003) 1.00
A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J Allergy Clin Immunol (2005) 0.99
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering. Mol Immunol (2008) 0.99
Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol (2012) 0.99
Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J Allergy Clin Immunol (2013) 0.98
FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol (2004) 0.98
A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol (2009) 0.98
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. J Allergy Clin Immunol (2009) 0.97
Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol (2012) 0.97
Mast cell-derived proteases control allergic inflammation through cleavage of IgE. J Allergy Clin Immunol (2007) 0.97
Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity. J Allergy Clin Immunol (2011) 0.97
Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol (2006) 0.96
Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol (2007) 0.96
Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants. J Allergy Clin Immunol (2006) 0.96
Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy. Int Arch Allergy Immunol (2008) 0.95
Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy. J Allergy Clin Immunol (2011) 0.95
The role of histamine in regulation of immune responses. Chem Immunol Allergy (2006) 0.95
Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol (2011) 0.95